Physicochemical stimulus-responsive systems targeted with antibody derivatives

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Physicochemical stimulus-responsive systems targeted with antibody derivatives. / Mohammadi, Rezvan ; Ghani, Sepideh ; Arezumand , Roghaye; Farhadi, Shohreh ; Khazaee-Poul, Yalda ; Kazemi, Bahram ; Yarian, Fatemeh ; Noruzi, Somaye ; Alibakhshi , Abbas ; Jalili, Mahsa; Aghamiri, Shahin .

I: Current Molecular Medicine, 2023.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Mohammadi, R, Ghani, S, Arezumand , R, Farhadi, S, Khazaee-Poul, Y, Kazemi, B, Yarian, F, Noruzi, S, Alibakhshi , A, Jalili, M & Aghamiri, S 2023, 'Physicochemical stimulus-responsive systems targeted with antibody derivatives', Current Molecular Medicine. https://doi.org/10.2174/1566524023666230818093016

APA

Mohammadi, R., Ghani, S., Arezumand , R., Farhadi, S., Khazaee-Poul, Y., Kazemi, B., Yarian, F., Noruzi, S., Alibakhshi , A., Jalili, M., & Aghamiri, S. (2023). Physicochemical stimulus-responsive systems targeted with antibody derivatives. Current Molecular Medicine. https://doi.org/10.2174/1566524023666230818093016

Vancouver

Mohammadi R, Ghani S, Arezumand R, Farhadi S, Khazaee-Poul Y, Kazemi B o.a. Physicochemical stimulus-responsive systems targeted with antibody derivatives. Current Molecular Medicine. 2023. https://doi.org/10.2174/1566524023666230818093016

Author

Mohammadi, Rezvan ; Ghani, Sepideh ; Arezumand , Roghaye ; Farhadi, Shohreh ; Khazaee-Poul, Yalda ; Kazemi, Bahram ; Yarian, Fatemeh ; Noruzi, Somaye ; Alibakhshi , Abbas ; Jalili, Mahsa ; Aghamiri, Shahin . / Physicochemical stimulus-responsive systems targeted with antibody derivatives. I: Current Molecular Medicine. 2023.

Bibtex

@article{5e5244a70677475eb645c5d83295a2a8,
title = "Physicochemical stimulus-responsive systems targeted with antibody derivatives",
abstract = "The application of monoclonal antibodies and antibody fragments with the advent of recombinant antibody technology has made notable progress in clinical trials to provide a regulated drug release and extra targeting to the special conditions in the function site. Modification of antibodies has facilitated using mAbs and antibody fragments in numerous models of therapeutic and detection utilizations, such as stimuli-responsive systems. Antibodies and antibody derivatives conjugated with diverse stimuli-responsive materials have been constructed for drug delivery in response to a wide range of endogenous (electric, magnetic, light, radiation, ultrasound) and exogenous (temperature, pH, redox potential, enzymes) stimuli. In this report, we highlighted the recent progress on antibody-conjugated stimuli-responsive and dual/multi-responsive systems that affect modern medicine by improving a multitude of diagnostic and treatment strategies.",
keywords = "Faculty of Science, Stimulus-responsive systems, Derivatives of antibody, Targeted delivery of antibody, Antibody, Endogenous and exogenous stimuli",
author = "Rezvan Mohammadi and Sepideh Ghani and Roghaye Arezumand and Shohreh Farhadi and Yalda Khazaee-Poul and Bahram Kazemi and Fatemeh Yarian and Somaye Noruzi and Abbas Alibakhshi and Mahsa Jalili and Shahin Aghamiri",
note = "CURIS 2023 NEXS 184",
year = "2023",
doi = "10.2174/1566524023666230818093016",
language = "English",
journal = "Current Molecular Medicine",
issn = "1566-5240",
publisher = "Bentham Science Publishers",

}

RIS

TY - JOUR

T1 - Physicochemical stimulus-responsive systems targeted with antibody derivatives

AU - Mohammadi, Rezvan

AU - Ghani, Sepideh

AU - Arezumand , Roghaye

AU - Farhadi, Shohreh

AU - Khazaee-Poul, Yalda

AU - Kazemi, Bahram

AU - Yarian, Fatemeh

AU - Noruzi, Somaye

AU - Alibakhshi , Abbas

AU - Jalili, Mahsa

AU - Aghamiri, Shahin

N1 - CURIS 2023 NEXS 184

PY - 2023

Y1 - 2023

N2 - The application of monoclonal antibodies and antibody fragments with the advent of recombinant antibody technology has made notable progress in clinical trials to provide a regulated drug release and extra targeting to the special conditions in the function site. Modification of antibodies has facilitated using mAbs and antibody fragments in numerous models of therapeutic and detection utilizations, such as stimuli-responsive systems. Antibodies and antibody derivatives conjugated with diverse stimuli-responsive materials have been constructed for drug delivery in response to a wide range of endogenous (electric, magnetic, light, radiation, ultrasound) and exogenous (temperature, pH, redox potential, enzymes) stimuli. In this report, we highlighted the recent progress on antibody-conjugated stimuli-responsive and dual/multi-responsive systems that affect modern medicine by improving a multitude of diagnostic and treatment strategies.

AB - The application of monoclonal antibodies and antibody fragments with the advent of recombinant antibody technology has made notable progress in clinical trials to provide a regulated drug release and extra targeting to the special conditions in the function site. Modification of antibodies has facilitated using mAbs and antibody fragments in numerous models of therapeutic and detection utilizations, such as stimuli-responsive systems. Antibodies and antibody derivatives conjugated with diverse stimuli-responsive materials have been constructed for drug delivery in response to a wide range of endogenous (electric, magnetic, light, radiation, ultrasound) and exogenous (temperature, pH, redox potential, enzymes) stimuli. In this report, we highlighted the recent progress on antibody-conjugated stimuli-responsive and dual/multi-responsive systems that affect modern medicine by improving a multitude of diagnostic and treatment strategies.

KW - Faculty of Science

KW - Stimulus-responsive systems

KW - Derivatives of antibody

KW - Targeted delivery of antibody

KW - Antibody

KW - Endogenous and exogenous stimuli

U2 - 10.2174/1566524023666230818093016

DO - 10.2174/1566524023666230818093016

M3 - Review

C2 - 37594115

JO - Current Molecular Medicine

JF - Current Molecular Medicine

SN - 1566-5240

ER -

ID: 362797689